Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 6/20 | 0.47 |
| ▸ | LMNA | P02545 | 5/20 | 0.43 |
| ▸ | NPC1 | O15118 | 4/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 3/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CTSC | P53634 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL160010 | 1.00 | CYP2C19 (0.50) | CYP2C19RAB9ALMNANPC1SMN1; SMN2 | |
| SCHEMBL21116925 | 0.84 | CYP2C19 (0.47) | CYP2C19RAB9ALMNANPC1SMN1; SMN2 | |
| SCHEMBL30532987 | 0.82 | CYP2C19 (0.42) | CYP2C19RAB9ALMNANPC1SMN1; SMN2 | |
| SCHEMBL8555164 | 0.82 | CYP2C19 (0.48) | CYP2C19RAB9ALMNANPC1SMN1; SMN2 | |
| SCHEMBL10496977 | 0.81 | CYP2C19 (0.44) | CYP2C19RAB9ALMNANPC1SMN1; SMN2 | |
| SCHEMBL19822079 | 0.81 | CYP2C19 (0.52) | CYP2C19RAB9ALMNASMN1; SMN2HPGD | |
| SCHEMBL91135 | 0.80 | — | — | |
| Hydrochloric Acid SCHEMBL6138354 | 0.80 | RAB9A (0.49) | CYP2C19RAB9ALMNANPC1SMN1; SMN2 | |
| SCHEMBL19185640 | 0.80 | TAAR1 (0.48) | CYP2C19RAB9ASMN1; SMN2GAAHTT | |
| SCHEMBL25306777 | 0.79 | CYP2C19 (0.50) | CYP2C19RAB9ALMNANPC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2612376-B1 | SEMICONDUCTING COMPOUNDS AND RELATED COMPOSITIONS AND DEVICES | FLEXTERRA INC (US) | 2018-11-21 | — | — | EP | disclosed |
| US-8598575-B2 | Semiconducting compounds and related compositions and devices | POLYERA CORPORATION (US) | 2013-12-03 | — | — | US | disclosed |
| EP-2612376-A2 | SEMICONDUCTING COMPOUNDS AND RELATED COMPOSITIONS AND DEVICES | Polyera Corporation (US) | 2013-07-10 | — | — | EP | disclosed |
| US-20130168659-A1 | Semiconducting Compounds and Related Compositions and Devices | POLYERA CORPORATION (US) | 2013-07-04 | — | — | US | disclosed |
| WO-2012030662-A2 | SEMICONDUCTING COMPOUNDS AND RELATED COMPOSITIONS AND DEVICES | POLYERA CORPORATION (US) | 2012-03-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130168659-A1 | Semiconducting Compounds and Related Compositions and Devices | NES, TST, SLC19A2 | CYP2C19 218/4885RAB9A 3260/4885LMNA 3641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.